To analyze the nuclear RNAs modified by the m6A mark Overall design: Nuclear RNA was extracted from MDA-MB-231 cells and was immunoprecipitated with an antibody against m6A or an IgG control
We developed a ssRNA binding low molecular compound, KN69. KN69 showed therapeutic effect on mice RA and SLE models. To clarify the endogenous target RNA of KN69, we clarified KN69 binding RNAs by RNA
